Ticker Details
Exagen Inc.
IPO Date:	September 20, 2019
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$102.92M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.72%
Avg Daily Range (30 D):	$0.13 | 3.95%
Avg Daily Range (90 D):	$0.13 | 3.58%

Institutional Daily Volume
Avg Daily Volume:	.09M
Avg Daily Volume (30 D):	.46M
Avg Daily Volume (90 D):	.42M

Trade Size
Avg Trade Size (Sh.):	106
Avg Trade Size (Sh.) (30 D):	100
Avg Trade Size (Sh.) (90 D):	106

Institutional Trades
Total Institutional Trades:	73
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$.64M
Avg Institutional Trade (90 D):	$1.21M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.23M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$.64M
Avg Closing Volume:	215.41K

News

Feb 24, 2026 @ 2:00 PM Exagen Inc. to Announce Fourth Quarter and Full Ye... Source: Na

Jan 11, 2026 @ 8:00 PM Exagen Inc. Announces Select Preliminary 2025 Fina... Source: Na

Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas

Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research

Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.89	$-.17	$-.2
Diluted EPS	$-.89	$-.17	$-.2
Revenue	$68.38M	$17.31M	$16.63M
Gross Profit	$39.88M	$10.21M	$9.21M
Net Income / Loss	$-20.17M	$-3.97M	$-4.67M
Operating Income / Loss	$-14.12M	$-3.41M	$-4.98M
Cost of Revenue	$28.5M	$7.1M	$7.43M
Net Cash Flow	$10.32M	$-10.71M	$-3.43M
PE Ratio